Issued: July 2012.
Adalimumab for the treatment of moderate to severe ulcerative colitis (terminated appraisal) by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2012. Publication and catalogue information, links to buy online and reader comments.